Clinical Trials Logo
  1. Home
  2. Acute Ischemic Stroke
  3. NCT06220981
  4. Details
NCT06220981 Clinical Trial

The Oslo Acute Reperfusion Stroke Study (OSCAR)

Acute Ischemic Stroke Clinical Trial

— OSCAR  

Official title:
The Oslo Acute Reperfusion Stroke Study (OSCAR)

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06220981
Other study ID # 2015-17637
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 10, 2017
Est. completion date December 31, 2025

Study information
Verified date January 2024
Source Oslo University Hospital
Contact Anne Hege Aamodt
Phone 97417734
Email anne.hege.aamodt@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.

Recruitment information / eligibility
Status Recruiting
Enrollment 1500
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization. - All stroke severities and vascular distributions are eligible. - Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines. Exclusion criteria: • Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Endovascular treatment

Locations
Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)
Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome
Type Measure Description Time frame Safety issue
Primary Modified Rankin Scale Score Modified Rankin Scale Score (mRS), min 0, max 6 3 months
Secondary National Institute of Health Stroke Scale Score National Institute of Health Stroke Scale Score (NIHSS, min 0, max 42) discharge
Secondary Death due to any cause Mortality 3 months
Secondary Infarct volume Infarct volume (ml) 1 day
Secondary Incidence of symptomatic intracranial hemorrhage Incidence of symptomatic intracranial hemorrhage (SICH) 1 day
Secondary Volume of new areas of diffusion restriction Volume of new areas of diffusion restriction 1 day
Secondary serious adverse events serious adverse events 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06113848 - Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy Phase 3
Completed NCT04069546 - The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency N/A
Active, not recruiting NCT05700097 - Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Phase 2
Recruiting NCT06058130 - Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis N/A
Recruiting NCT04415164 - Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Phase 4
Recruiting NCT05363397 - Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke Phase 2
Completed NCT05429658 - Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System N/A
Recruiting NCT05390580 - Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct N/A
Enrolling by invitation NCT05515393 - A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Phase 2
Active, not recruiting NCT05070260 - ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo Phase 2/Phase 3
Terminated NCT05547412 - Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
Completed NCT03366818 - New Stent Retriever, VERSI System for AIS N/A
Not yet recruiting NCT05293080 - Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE Phase 3
Not yet recruiting NCT06040476 - Human Umbilical Cord Blood Infusion in Patients With Acute Ischemic Stroke (AIS) Phase 2
Completed NCT02223273 - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke) N/A
Completed NCT02586233 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Phase 1/Phase 2
Terminated NCT01694381 - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor Early Phase 1
Not yet recruiting NCT01594190 - Physical Activity Immediately After Acute Cerebral Ischemia N/A
Completed NCT01120301 - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Phase 3
Completed NCT00963989 - Imaging Guided Patient Selection for Interventional Revascularization Therapy N/A